XAIR Quote, Financials, Valuation and Earnings

NeuroOne Medical Technologies has a net margin of -1215.67% compared to Beyond Air's net margin of -163.76%. Beyond Air's return on equity of -225.36% beat NeuroOne Medical Technologies's return on equity of -281.01%.

Beyond Air has a consensus price target of $2.25, signalling upside risk potential of 1133.55%. On the other hand NeuroOne Medical Technologies has an analysts' consensus of $1.45 which suggests that it could grow by 137.28%. Given that Beyond Air has higher upside potential than NeuroOne Medical Technologies, analysts believe Beyond Air is more attractive than NeuroOne Medical Technologies.

Beyond Air has a beta of 0.230, which suggesting that the stock is 76.973% less volatile than S&P 500. In comparison NeuroOne Medical Technologies has a beta of 0.725, suggesting its less volatile than the S&P 500 by 27.531%.

Beyond Air has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. NeuroOne Medical Technologies offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Beyond Air pays -- of its earnings as a dividend. NeuroOne Medical Technologies pays out -- of its earnings as a dividend.

Beyond Air quarterly revenues are $1.1M, which are smaller than NeuroOne Medical Technologies quarterly revenues of $1.4M. Beyond Air's net income of -$13M is lower than NeuroOne Medical Technologies's net income of -$2.3M. Notably, Beyond Air's price-to-earnings ratio is -- while NeuroOne Medical Technologies's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Beyond Air is 3.29x versus 3.16x for NeuroOne Medical Technologies. Usually stocks with elevated PS ratios are considered overvalued.

Nutriband has a net margin of -1215.67% compared to Beyond Air's net margin of -211%. Beyond Air's return on equity of -225.36% beat Nutriband's return on equity of -69.58%.

Beyond Air has a consensus price target of $2.25, signalling upside risk potential of 1133.55%. On the other hand Nutriband has an analysts' consensus of $13.00 which suggests that it could grow by 100%. Given that Beyond Air has higher upside potential than Nutriband, analysts believe Beyond Air is more attractive than Nutriband.

Beyond Air has a beta of 0.230, which suggesting that the stock is 76.973% less volatile than S&P 500. In comparison Nutriband has a beta of 1.187, suggesting its more volatile than the S&P 500 by 18.694%.

Beyond Air has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Nutriband offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Beyond Air pays -- of its earnings as a dividend. Nutriband pays out -- of its earnings as a dividend.

Beyond Air quarterly revenues are $1.1M, which are larger than Nutriband quarterly revenues of $645.8K. Beyond Air's net income of -$13M is lower than Nutriband's net income of -$1.4M. Notably, Beyond Air's price-to-earnings ratio is -- while Nutriband's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Beyond Air is 3.29x versus 32.23x for Nutriband. Usually stocks with elevated PS ratios are considered overvalued.

enVVeno Medical has a net margin of -1215.67% compared to Beyond Air's net margin of --. Beyond Air's return on equity of -225.36% beat enVVeno Medical's return on equity of --.

Beyond Air has a consensus price target of $2.25, signalling upside risk potential of 1133.55%. On the other hand enVVeno Medical has an analysts' consensus of $12.50 which suggests that it could grow by 246.26%. Given that Beyond Air has higher upside potential than enVVeno Medical, analysts believe Beyond Air is more attractive than enVVeno Medical.

Beyond Air has a beta of 0.230, which suggesting that the stock is 76.973% less volatile than S&P 500. In comparison enVVeno Medical has a beta of 0.922, suggesting its less volatile than the S&P 500 by 7.843%.

Beyond Air has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. enVVeno Medical offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Beyond Air pays -- of its earnings as a dividend. enVVeno Medical pays out -- of its earnings as a dividend.

Beyond Air quarterly revenues are $1.1M, which are larger than enVVeno Medical quarterly revenues of --. Beyond Air's net income of -$13M is lower than enVVeno Medical's net income of -$4.5M. Notably, Beyond Air's price-to-earnings ratio is -- while enVVeno Medical's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Beyond Air is 3.29x versus 352.17x for enVVeno Medical. Usually stocks with elevated PS ratios are considered overvalued.

SINTX Technologies has a net margin of -1215.67% compared to Beyond Air's net margin of -787.63%. Beyond Air's return on equity of -225.36% beat SINTX Technologies's return on equity of -180.99%.

Beyond Air has a consensus price target of $2.25, signalling upside risk potential of 1133.55%. On the other hand SINTX Technologies has an analysts' consensus of $28.00 which suggests that it could grow by 933.21%. Given that Beyond Air has higher upside potential than SINTX Technologies, analysts believe Beyond Air is more attractive than SINTX Technologies.

Beyond Air has a beta of 0.230, which suggesting that the stock is 76.973% less volatile than S&P 500. In comparison SINTX Technologies has a beta of 0.726, suggesting its less volatile than the S&P 500 by 27.368%.

Beyond Air has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. SINTX Technologies offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Beyond Air pays -- of its earnings as a dividend. SINTX Technologies pays out -- of its earnings as a dividend.

Beyond Air quarterly revenues are $1.1M, which are larger than SINTX Technologies quarterly revenues of $291K. Beyond Air's net income of -$13M is lower than SINTX Technologies's net income of -$2.3M. Notably, Beyond Air's price-to-earnings ratio is -- while SINTX Technologies's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Beyond Air is 3.29x versus 2.60x for SINTX Technologies. Usually stocks with elevated PS ratios are considered overvalued.